|
Feb 13
|
DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue
|
|
Feb 13
|
DexCom: Q4 Earnings Snapshot
|
|
Feb 13
|
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
|
|
Feb 12
|
Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy?
|
|
Feb 12
|
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
|
|
Feb 12
|
Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?
|
|
Feb 11
|
DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact?
|
|
Feb 10
|
Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
|
|
Jan 4
|
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
|
|
Jan 2
|
Abbott, Dexcom settle glucose monitor patent lawsuits
|
|
Jan 1
|
The 5 worst performing stocks on the Nasdaq 100 in 2024
|
|
Dec 31
|
DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy
|
|
Dec 10
|
Dexcom shares up as Diabetes Association updates guidelines
|
|
Dec 6
|
Investing in DexCom (NASDAQ:DXCM) five years ago would have delivered you a 56% gain
|